15-year liver outcomes after metabolic surgery in patients with compensated cirrhosis due to metabolic dysfunction-associated steatohepatitis (MASH)

被引：0
|
作者：
Aminian, Ali [1 ]
ALJabri, Abdullah [1 ]
Wang, Sarah [1 ]
Bena, James [1 ]
Allende, Daniela [1 ]
Rosen, Hana [1 ]
Wilson, Rickesha [1 ]
Milinovich, Alex [1 ]
Loomba, Rohit [2 ]
Sanyal, Arun J. [3 ]
Alkhouri, Naim [4 ]
Wakim-Fleming, Jamile [1 ]
Dasarathy, Srinivasan [1 ]
McCullough, Arthur [1 ]
Nissen, Steven [1 ]
机构：
[1] Cleveland Clin, Cleveland, OH USA
[2] Univ Calif San Diego, La Jolla, CA USA
[3] Virginia Commonwealth Univ, Richmond, VA USA
[4] Arizona Liver Hlth, Phoenix, AZ USA
来源：
JOURNAL OF HEPATOLOGY | 2024年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
OS-125
引用
收藏
页码：S76 / S77
页数：2
相关论文
共 50 条
  • [1] Long-term liver outcomes after metabolic surgery in compensated cirrhosis due to metabolic dysfunction-associated steatohepatitis
    Aminian, Ali
    Aljabri, Abdullah
    Wang, Sarah
    Bena, James
    Allende, Daniela S.
    Rosen, Hana
    Arnold, Eileen
    Wilson, Rickesha
    Milinovich, Alex
    Loomba, Rohit
    Sanyal, Arun J.
    Alkhouri, Naim
    Wakim-Fleming, Jamile
    Laique, Sobia N.
    Dasarathy, Srinivasan
    Mccullough, Arthur J.
    Nissen, Steven E.
    NATURE MEDICINE, 2025, : 988 - 995
  • [2] REAL-WORLD OUTCOMES OF PATIENTS WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS (MASH) COMPENSATED CIRRHOSIS AT A LARGE ACADEMIC REFERRAL CENTER
    Slatter, Shadera
    Guillot, Jordan
    Williams, Christopher
    Watanabe, Alexandre
    Chaudhri, Eirum
    Zhang, Xiao
    Fernandes, Gail
    Ge, Jin
    Rudrapatna, Vivek
    HEPATOLOGY, 2024, 80 : S860 - S861
  • [3] Platelet dynamics in metabolic patients with metabolic dysfunction-associated steatotic liver disease/steatohepatitis and liver cirrhosis
    Zoncape, Mirko
    Castelli, Marco
    Sacerdoti, David
    Minuz, Pietro
    Dalbeni, Andrea
    JOURNAL OF HEPATOLOGY, 2024, 80 : S492 - S493
  • [4] Therapeutic landscape of metabolic dysfunction-associated steatohepatitis (MASH)
    Do, Albert
    Zahrawi, Frhaan
    Mehal, Wajahat Z.
    NATURE REVIEWS DRUG DISCOVERY, 2025, 24 (03) : 171 - 189
  • [5] Therapeutic landscape of metabolic dysfunction-associated steatohepatitis (MASH)
    Do, Albert
    Zahrawi, Frhaan
    Mehal, Wajahat Z.
    NATURE REVIEWS DRUG DISCOVERY, 2024,
  • [6] Therapeutic landscape of metabolic dysfunction-associated steatohepatitis (MASH)
    Albert Do
    Frhaan Zahrawi
    Wajahat Z. Mehal
    Nature Reviews Drug Discovery, 2025, 24 (3) : 171 - 189
  • [7] Metabolic issues in patients with metabolic dysfunction-associated steatohepatitis (MASH) and their impact on MASH recurrence following liver transplantation: A narrative review
    Alnimer, Lynna
    Arellano, Diego
    Brombosz, Elizabeth
    Noureddin, Mazen
    LIVER TRANSPLANTATION, 2024,
  • [8] Silent MASH: A Case of Metabolic Dysfunction-Associated Steatohepatitis (MASH) with Normal Aminotransferases
    Li, Elizabeth
    Vallabhaneni, Manasa
    Lin, Joanne
    Hogan, Carolyn
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S2778 - S2778
  • [9] Metabolic dysfunction-associated steatohepatitis (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) require urgent attention by primary care physicians and endocrinologists
    Mauricio, Didac
    Escalada, Javier
    Perez, Antonio
    Romero-Gomez, Manuel
    Cusi, Kenneth
    Younoussi, Zobair M.
    Lazarus, Jeffrey V.
    ENDOCRINOLOGIA DIABETES Y NUTRICION, 2024, 71 (04): : 149 - 151
  • [10] IMPACT OF METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS CIRRHOSIS ON INPATIENT OUTCOMES AFTER ACUTE MYOCARDIAL INFARCTION
    Khan, Muhammad Jahanzaib
    Haseeb, Shahan
    Iqbal, Amna
    Taj, Sobaan
    Patel, Himani
    Ali, Hassam
    Zulqarnain, Muhammad Ali
    GASTROENTEROLOGY, 2024, 166 (05) : S1643 - S1644
12345